Medication info
DinoGen Tablets (Calidino-genase)

DinoGen Tablets (Calidino-genase)

Prescription medicationTabletOral
Ingredient · strength
Kallidinogenase›Strength being verified
Manufacturer / importer
Vivozon Pharmaceutical Co., Ltd.
Appearance
Red round enteric-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201707263 · Approved 2017.09.28

Summary

Main use
Improvement of symptoms of peripheral circulatory disorders (such as hypertension), chorioretinal circulatory disorders, and menopausal disorders
Who takes it
Adults
Adult dose
Administer 30~150I.U. daily orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Vivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of peripheral circulatory disorders (such as hypertension), chorioretinal circulatory disorders, and menopausal disorders

  • Peripheral circulation disorders
  • hypertension
  • Meniere's disease
  • occlusive thromboangitis
  • menopausal disorders
  • impaired blood circulation in the retina
View approved original text

This drug is effective for peripheral circulation disorders such as hypertension, Meniere's disease, and occlusive thromboangitis. It also helps improve menopausal disorders and symptoms caused by impaired retinal or choroidal blood circulation. Through these effects, it facilitates blood circulation and effectively treats related symptoms.

How to take

Adult dose

Administer 30~150I.U. daily orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients with cerebral hemorrhage or ongoing bleeding. Additionally, this drug contains lactose and should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption. When using this medication, allergic reactions may occur, so if skin rash or itching develops, treatment should be discontinued immediately. Rapid heartbeat may occur rarely, so caution is needed if such symptoms arise. In the gastrointestinal tract, symptoms such as stomach discomfort, nausea, vomiting, loss of appetite, abdominal pain, and diarrhea or constipation may occur. Furthermore, symptoms such as warmth, headache, dizziness, drowsiness, and fatigue may occasionally appear, requiring careful monitoring of the body condition. Elderly patients may have weakened physical function, so special caution should be taken in dosage adjustments when using this drug.

Side effects

  • Rash
  • itching
  • palpitations
  • discomfort in the upper abdomen
  • nausea
  • vomiting
  • loss of appetite
  • upper abdominal pain
  • diarrhea
  • constipation
Show 5 more
  • feverish sensation
  • headache
  • heaviness in the head
  • drowsiness
  • fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage can help maintain the drug's efficacy and safety for a longer period.

Appearance and packaging

Appearance

Red round enteric-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.